Prospect News: News for Angiotech Pharmaceuticals, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, HY only > All stories on Angiotech Pharmaceuticals, Inc. > Stories on Angiotech Pharmaceuticals, Inc., HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Angiotech Pharmaceuticals, Inc.

4/15/2013	CAHYLM	Angiotech calls all 9% floaters due 2013, 9% senior notes due 2016
4/2/2013	CAHY	Angiotech Pharmaceuticals ends 2012 with improved cash flow, $69 million liquidity, lower debt ratio
3/25/2013	CAHYLM	Angiotech to repay loans, buy back floaters and notes via asset sale
3/18/2013	CAHYLM	Angiotech to redeem $16 million of senior secured floaters due 2013
9/18/2012	CAHYLM	Angiotech plans to redeem $40 million, $22,000 of floaters due 2013
8/10/2012	CAHYLM	Angiotech wraps oversubscribed offer to exchange $225 million floaters
7/27/2012	CAHYLM	Angiotech extends floating-rate notes exchange offer, increases cap
7/3/2012	CAHYLM	Angiotech begins exchange offer for up to $200 million of floaters
4/10/2012	CAHY	Angiotech slashed debt load, leverage, confident about 2013 notes refi
3/16/2012	BKCAHYLM	Angiotech loosens loan terms, may now buy back floating-rate notes
8/11/2011	CAHY	Angiotech reorganizes for solid quarter; starts balance sheet anew
5/12/2011	CADDHYLM	Angiotech executes plan of arrangement, exchanges 73/4% notes, floaters
4/29/2011	CADDHYLM	Angiotech further extends exchange offer for floating-rate notes
4/25/2011	CADDHYLM	Angiotech recapitalization, exchange offer deadlines extended
3/30/2011	DDHYLM	Angiotech again extends exchange offer for floating-rate notes
3/4/2011	DDHYLM	Angiotech extends floating-rate notes exchange offer to March 30
2/24/2011	CADDHY	Angiotech, noteholders agree to amend exchange offer support agreement
2/9/2011	CADDHYLM	Angiotech noteholders extend exchange offer launch deadline to Feb. 10
1/28/2011	BKCADDHY	Moody's cuts Angiotech
1/28/2011	CADDHY	Angiotech to complete recapitalization via Canadian CCAA proceeding
1/26/2011	CADDHY	Angiotech license agreement terminated by Rex amid breach allegations
1/12/2011	CADDHY	Angiotech noteholders agree to extend exchange offer deadlines
12/22/2010	CADDHY	Angiotech 73/4% subordinated notes payment grace period extended
12/17/2010	DDHY	Angiotech noteholders agree to extend exchange offer launch deadlines
12/2/2010	DDHY	Angiotech exchange offer deadlines extended; Rex granted injunction
11/12/2010	HY	Distressed market 'kind of heavy'; market tone pressures NewPage; Angiotech creeping up
11/9/2010	BKCADDHY	Angiotech default forbearance, Wells Fargo credit agreement amended
11/2/2010	BKDDHY	Moody's lowers Angiotech
10/29/2010	BKCADDHY	Angiotech agrees with 73% of noteholders to exchange debt for stock
10/8/2010	BKCVDDEMHY	Prospect News records three new defaults for week; S&P marks two
10/4/2010	BKDDHY	S&P cuts Angiotech
10/1/2010	BKCADDHY	Angiotech skips subordinated notes payment amid noteholder talks
8/10/2010	BKDDHY	S&P drops Angiotech
11/9/2009	BKBWHY	Angiotech focused on reinvesting cash to grow business
11/9/2009	BKDDHYSS	Angiotech needs more liquidity to ensure survival beyond 2010
10/7/2009	BKDDHY	S&P upgrades Angiotech
7/23/2009	CVHY	Angiotech Pharmaceuticals files $250 million shelf registration
6/25/2009	BKDDHY	S&P may upgrade Angiotech
3/5/2009	BKBWHY	Angiotech says new Wells Fargo credit facility addresses near-term liquidity needs
2/4/2009	HY	Market Commentary: El Paso, Landry's bring deals at discount; NOVA jumps on funding deal report; gaming names clobbered again
12/31/2008	BKHY	S&P affirms Angiotech
12/17/2008	BKDDHY	S&P affirms Angiotech
9/23/2008	BKDDHY	S&P keeps Angiotech on watch
9/23/2008	BKDDHY	Moody's drops Angiotech
9/23/2008	HY	Angiotech cancels tender for $165 million of floaters, 73/4% notes
9/12/2008	HY	Angiotech again prolongs tender deadline for $165 million of floaters, 73/4% notes
8/22/2008	HY	Angiotech delays tender deadline for $165 million of floaters, 73/4% notes
7/8/2008	BKDDHY	S&P lowers Angiotech
7/7/2008	HY	Angiotech tenders for $165 million of floaters, 73/4% notes
7/2/2008	BKHY	Moody's may lower Angiotech
4/3/2008	HY	Market Commentary: Bombardier, Finlay bonds rise on earnings; Thornburg rally fizzles out; funds see $373 million inflow
10/24/2007	BKHY	Moody's lowers Angiotech
10/22/2007	BKHY	S&P: Angiotech on watch
10/19/2007	HY	Market Commentary: US Investigations prices; Angiotech slides on earnings warning; Trump, GMAC ease in active dealings
8/7/2007	BKHY	S&P lowers Angiotech
3/23/2007	BKHY	S&P lowers Angiotech outlook to negative
3/13/2007	BKHY	Moody's downgrades Angiotech
11/30/2006	BKHY	Moody's cuts Angiotech, rates note Ba3
11/30/2006	HY	New Issue: Angiotech $325 million seven-year notes yield Libor plus 375 bps
11/30/2006	HY	Market Commentary: VWR, United Auto price; GM bonds up on GMAC deal closing; funds see $249 million outflow
11/29/2006	HY	Angiotech talks $325 million seven-year notes at Libor plus 325-350 bps
11/29/2006	HY	Market Commentary: Momentive, Complete Production price; Revlon up on financing, Houghton Mifflin on M&A
11/28/2006	HY	Market Commentary: Airline slide continues, market mulls Harrah's buzz; Chesapeake, OPTI Canada slate deals
11/27/2006	HY	Angiotech offers $325 million seven-year floating-rate notes via Credit Suisse, Banc of America Securities
11/27/2006	HY	Market Commentary: Ford weathers triple ratings hit; Six flags off; Regency Energy slates deal; funds see $25 million outflow
9/28/2006	BKDDHY	Moody's introduces new ratings
3/17/2006	HY	Market Commentary: GM loss restatement, reporting delay tows autos lower; SBA gains
3/16/2006	HY	Market Commentary: Angiotech deal prices; Young up on KRON joining network; funds see $404 million outflow
3/16/2006	BTHY	New Issue: Angiotech sells $250 million eight-year notes to yield 73/4%
3/13/2006	HY	Market Commentary: Quicksilver prices upsized deal; Aztar bonds up on merger news
3/13/2006	BTHY	Angiotech Pharmaceuticals talks $250 million eight-year notes at 73/4%-8%
3/10/2006	HY	Market Commentary: Levi Strauss two-part deal prices; Dana keeps heading north
3/3/2006	BKBTHY	S&P assigns Angiotech Pharmaceuticals, loan BB-, notes B
3/3/2006	HY	Market Commentary: Dave & Buster's prices eight-year deal; AK up on takeover buzz; bankrupt Dana climbs
3/3/2006	BTHY	Angiotech Pharmaceuticals to start roadshow for $250 million eight-year notes Tuesday
3/2/2006	BKBTHY	Moody's rates Angiotech Pharmaceutical loan Ba3, notes B2
2/1/2006	BKBTHY	Angiotech plans $375 million credit facility, $300 million bonds for American Medical purchase

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.